News and Events

Topics

  • Public statement regarding recent lawsuit settlement

    Topcon Healthcare is pleased to announce we have reached a positive resolution to a lawsuit with Carl Zeiss Meditec that has been a distraction for over four years. Topcon made a strategic decision to settle ongoing litigation with Zeiss to remove the distraction and allow us to focus on our mission to serve our customers and help improve access and quality of care while reducing the overall cost of care. We are known for quality products and quality people.  We intend to continue delivering value and intelligent solutions to our customers and the healthcare market.  Topcon admitted no wrongdoing in the settlement.  During the (4 years of) litigation almost all of Zeiss’s claims were dismissed or withdrawn.  The final settlement relates to a legacy version of Harmony (which has not been actively licensed by Topcon for several years).  Customers using our current product, Harmony RS, are not affected by the settlement, and none of the devices or software that we are promoting or plan to implement in the future are affected by the conditions in the settlement in any way. 

  • Establishment of Topcon Korea Medical Co., Ltd.

    Located in Seoul, Korea, Topcon Korea Medical Co., Ltd. (TKM) was established and formally launched in 2023. Topcon Healthcare, via TKM, will pursue better clinical processes and outcomes for customers and their patients in Korea. Topcon Corporation (HQ: Itabashi-ku, Tokyo; President: Takashi Eto) (henceforth Topcon) has established Topcon Korea Medical Co., Ltd. (HQ: Seoul, South Korea, President : Artur Chu) (henceforth TKM) to strengthen and expand its eye care business in South Korea. The company was registered in March 2023, and full-scale sales and marketing operations began in the second half of 2023 after the company's infrastructure and team staff were established.In South Korea, as in other developed countries, as the government is responding to the increase in eye disease associated with an ageing population South Korea is focusing on a strategy of early detection and treatment applied broadly across the eye care sector to meet the high and increasing demand for examination through treatment.Optical stores market in Korea is different domain. It is highly competitive. Global economy and COVID-19 affects seriously, however in accordance with increased demand for good quality lenses for myopia and presbyopia, business opportunities are recovering. TKM also is ready to contribute here to optimize the workflow and profitable management. Topcon Korea Medical is a strong partner for all eye care professionals, providing innovative products and services required by customers in the fields of optometry and ophthalmology, as well as new businesses including health check-up and screening services, to contribute to optimal patient care. Message from the president"Introducing Topcon Korea Medical Co., Ltd. Empowering Excellence in the Korean Market. With a firm foundation built on understanding the unique needs of the Korean market, TKM is poised to revolutionize the industry landscape.Our dedication to quality, innovation, and a deep cultural understanding ensures that we not only meet, but exceed the expectations of our Korean partners. Join us on this exciting journey as we redefine possibilities in Korea and beyond."Artur Chu,Learn More about Topcon korea medical

  • TOPCON selected for the fourth consecutive year as a Digital Transformation Stock (DX stock), and first time chosen for the DX Grand Prix!

    Topcon Corporation (Headquarters: Itabashi, Tokyo; President and CEO: Takashi Eto) has been selected for the DX Grand Prix 2023 in the Digital Transformation Stock (DX Stock) designated by the METI (Ministry of Economy, Trade, and Industry) and the Tokyo Stock Exchange.DX Stocks are selected for each industry category, targeting companies listed on the Tokyo Stock Exchange that have established internal systems to promote DX that contributes to improving corporate value. These companies fundamentally transform their business models based on digital technologies and aim to achieve new growth and enhance their competitiveness through digital transformation.Topcon has been selected for four consecutive years since 2020, and this year was chosen as a “DX Grand Prix company,” an award for being a leading company in the selected stocks.Topcon’s corporate identity is “Topcon contributes to enrich human life by solving the societal challenges within healthcare, agriculture, and infrastructure.” We have been creating new markets by providing DX solutions that transform conventional work processes through digitization, automation, and networking technologies in the global healthcare, agriculture, and infrastructure markets.■ Topcon’s DX Solutions for Solving Societal Challenges in Healthcare, Agriculture, and Infrastructure.[DX Grand Prix 2023 Evaluation Points]Topcon places DX as a driving force for business transformation, and the evaluation points are comprehensive and specific in terms of contributing to corporate value and realization capabilities. The corporate identity states that ” Topcon contributes to enrich human life by solving the societal challenges within healthcare, agriculture, and infrastructure.” and aims to solve these issues with DX solutions. The company actively engages in M&A and partnerships, incorporating advanced technologies and expanding services. They provide integrated solutions that combine technology and services, not just selling products or services, to address the challenges in the target industries. Expectations are high for future developments.Going forward, with a customer-oriented, field-oriented approach and a spirit of challenge, we will continue to strive for “the company that is needed” by stakeholders and promote ESG (environmental, social, and governance) management through our business

SEE MORE

News

  • Topcon Healthcare Inc. partners with Microsoft to deliver AI-powered ‘Healthcare from the Eye’ through a connected healthcare platform

    Topcon Healthcare Inc (THI) announces a partnership with Microsoft Corporation to deliver AI-powered ‘healthcare from the eye’ solutions to improve healthcare access, cost, and quality. A cloud-based connected network of healthcare providers using the Nuance Precision Imaging Network and the THI Harmony platform will empower patients and healthcare providers to participate in pre-screening for systemic and neurological disease via a robotic, rapid, and non-invasive eye scan. “We are committed to making healthcare accessible and affordable through pre-screening using oculomics-leveraging the eye for insights into systemic and neurological health. We call this, Healthcare from the Eye. A key element of this effort is Harmony – a vendor-inclusive, secure, connected data management platform,” said Ali Tafreshi, CEO & President of Topcon Healthcare Inc.Since establishing the Microsoft collaboration in February of 2024, THI has initiated several projects to drive the mission forward. A collaboration with the University of California, San Diego aims to show the value of AI-powered screening and coordinated care of diabetic patients across primary care, optometry, and ophthalmology. “Healthcare from the Eye is no longer just a concept; it is the future of healthcare,” said Robert N. Weinreb, MD, Chair and Distinguished Professor of Ophthalmology, University of California, San Diego.To accelerate AI research and innovation for Healthcare from the Eye, THI established the Institute for Digital Health (IDHea). IDHea, a large, secure, population database platform, is governed by an external data access and governance (DAG) committee to ensure fair and ethical access to data. IDHea is engaged in multiple research studies with organizations including Visionworks, Keplr Vision, and UC San Diego Health Shiley Eye Institute, integrating Microsoft Azure secure cloud-storage and advanced computing technologies to ensure data security and protect propriety algorithms. A proof-of-concept study involving National Vision Inc, Toku Inc, and BeeKeeperAI demonstrates that Toku’s AI-powered BioAge algorithm can be securely deployed in a large-scale clinical setting using BeeKeeperAI’s confidential computing technology and end-to-end encryption.AI technology is advancing at an unprecedented rate. Following best practices and implementing effective policy and safety measures are critical for successful deployment and containment of AI solutions. “Microsoft’s expertise in safe computing and AI provides a significant boost to our vendor-inclusive Harmony Network as a delivery environment for AI-powered decision support algorithms,” said Hideyuki Takizawa, Topcon Corporation, Senior Executive Officer, and Global Managing Director of the Eye Care Business division. www.topconhealthcare.com Additionally, the THI Corporate Venture Capital fund is enabling Healthcare from the Eye by investing in science-based AI innovators. “We are providing these AI partners funding, business consulting, and the ideal delivery platform to help accelerate commercialization of their AI solutions for healthcare,” said Fumio Ohue, SVP of Topcon Corporation and Chairman of THI.“Microsoft’s healthcare and AI expertise adds a powerful dimension to Topcon Healthcare’s vision to empower providers with smart and efficient technologies for enhanced patient care,” said Peter Durlach, Corporate Vice President, Chief Strategy Officer, Microsoft Health & Life Sciences. “With Microsoft Azure and the Precision Imaging Network, we provide the robust and secure cloud infrastructure essential for developing and deploying real-world applications at scale, integrated directly into provider workflows at the point of care.”About Topcon Healthcare, Inc.Topcon Healthcare, Inc. is part of Topcon Corporation (TSE 7732). Our vision is to improve access and quality of healthcare while decreasing the overall cost. To achieve this mission, we have established Harmony, a platform to accelerate the evolution of AI-powered algorithms that enable the detection of systemic, neurological, and ophthalmic disease markers even before discernable symptoms are present. Topcon Healthcare is investing in innovators focused on healthcare transformation with an emphasis on AI-powered digital Healthcare from the Eye. This approach helps doctors to prevent disease and, when needed, to treat at the earliest disease state for better, less costly outcomes.A truly global business, Topcon Corporation is focused on developing solutions to solve societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, physician shortages, and unequal access to healthcare. By investing in value-driven innovations, Topcon Corporation works to help people enjoy good health and a better quality of life.

  • Announcing Exclusive Partnership with Espansione Group

    Aimed at Driving Disruptive Innovation in Eye Care and Beyond in South-East AsiaTopcon Singapore Medical (referred to as “Topcon” in this document for brevity’s sake) and Espansione Group announce today a long-term exclusive partnership for the South-East Asia region.Starting April 1, 2023, Topcon will be the official and sole distributor for the South East Asian region of Espansione Group’s full portfolio, including light-based technologies such as Light Modulation® Low-level Light Therapy (LM® LLLT), its signature photobiomodulation technology, and Optimal Power Energy® Intense Pulsed Light (OPE® IPL).“We’re thrilled to grow our relationship with Topcon even stronger, including the South-East Asian region to our global collaboration efforts” commented Matteo Corbellino, Chief Marketing & Innovation Officer at Espansione Group. “We found a true partner in Topcon with a highly engaged and capable team striving to always deliver an extremely high level of service. We both want to raise the bar in the dry eye field and beyond, and that’s where we’ve found alignment. We believe that this partnership will create a powerful synergy that will enable us to push the boundaries of what’s possible in ophthalmology and beyond—as our technologies gain momentum worldwide, APAC and SEA in particular will be increasingly relevant for us.” “It's been Topcon Asia leadership's vision to look for ground-breaking type of collaborations. Our chance to meet the Espansione executive team gave us the opportunity to turn this vision into a reality” said Leo Nagatake, Managing Director at Topcon. “We see this strategic alliance with Espansione paving the way for our privileged access into their range of highly innovative and forward-thinking treatment products and solutions complementing the comprehensive range of Topcon's diagnostic equipment such as our MYAH - the unique multifunctional instrument for the management of dry eye & myopia. This synergistic partnership will further expand our service spectrum enabling us to provide more wholistic solutions to our esteemed clientele; from pre-diagnosis towards effective dry eye treatment followed by post treatment follow ups that will eventually benefit our end patients with a comprehensive end to end experience.”Professionals are encouraged to contact Topcon to obtain details on the portfolio of solutions in light therapy and digital imaging showcased with this partnership, including eye-light® , meibomask®, my-mask® and me-check®.About Espansione GroupEspansione Group is an established player in the medtech industry. Since 1981, Espansione Group has delivered the highest standard in the industry. Every day, the company invests heavily in researching and developing the Espansione Ecosystem to achieve its ambition: establishing new paradigms in ophthalmology and beyond, driven by its desire to provide its partners and their patients with the best, certified medical technologies, Light Modulation® Low-level Light Therapy (LM® LLLT) and Optimal Power Energy® Intense Pulsed Light (OPE® IPL). Present in over 50 countries, Espansione Group's aims to continue its strong growth in years to come, relentlessly focusing its efforts on research, development, and customer excellence.   For more information, see www.espansionegroup.itAbout Topcon HealthcareTopcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever-changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multi-modal imaging, vendor-neutral data management, safe distancing, and ground- breaking remote diagnostic technology.A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.For more information, see https://topconhealthcare.sgMedia ContactsEspansione GroupMatteo Corbellinomatteo.corbellino@espansione.itTopcon Singapore MedicalPatrick Foopfoo@topcon.com

  • Notice of Changes of President and CEO (Replacement of President)

    January 30, 2023Topcon Corporation (TSE: 7732) hereby announces that the change of President and CEO was resolved at a meeting of the board of directors held today. The appointments will take effect on April 1, 2023.Change of President and CEO(effective April 1, 2023)NameNew PositionCurrent PositionSatoshi HiranoRepresentative Director,ChairmanRepresentative Director,President & CEOTakashi EtoRepresentative Director,President & CEORepresentative Director,Executive Vice PresidentGeneral Manager, Quality Assurance Div.Takashi EtoTopcon Corporation, the parent company of all Topcon Healthcare companies, announced changes in their president and CEO position that will be effective with the new fiscal year. Takashi Eto will assume the position of Representative Director, President and CEO, effective April 1, 2023. Current Topcon Corporation President and CEO Satoshi Hirano has served in the role since 2013 and will continue to contribute to the development of Topcon as Chairman of the Board, assisting and advising the new president.Read the news on the Topcon Corporation Website : link

SEE MORE